John Stamos - Public Service Announcement
ADT & EVA™ Overview
Your patients are unique…their cancer therapies should be too.
By testing drugs and combinations on the patient's cancer cells in the laboratory, physicians can determine the best treatment regimen before it is administered to the patient. Rational Therapeutics assists physicians in establishing the most effective cancer treatment for a patient using a rational approach known as assay directed therapy.
Rational Therapeutics’ proprietary Ex Vivo Analysis-Programmed Cell Death (EVA-PCD™) assay incorporates the most advanced and accurate methodology for "functionally profiling" tumor cell sensitivity to various chemotherapy drugs., Using objective EVA-PCD™ assay data, Rational Therapeutics’ recommendations are made without financial or scientific prejudice.
The EVA-PCD™ assay is the subject of ongoing study and has already resulted in many heralded successful outcomes.
|
©2010 Rational Therapeutics. All rights reserved.